7 results on '"Pugliese, N."'
Search Results
2. P446 INDEPENDENT EFFECTS OF TYPE 2 DIABETES AND OBESITY ON CARDIOPULMONARY PERFORMANCE IN SUBJECTS AT HIGH CARDIOVASCULAR RISK
- Author
-
Nesti, L, Pugliese, N, Armenia, S, De Biase, N, Balletti, A, Tricò, D, and Natali, A
- Published
- 2023
- Full Text
- View/download PDF
3. Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
- Author
-
Picardi, M., Della Pepa, R., Giordano, C., Pugliese, N., Mortaruolo, C., Trastulli, F., Rascato, M. G., Cappuccio, I., Raimondo, M., Memoli, M., Monteverde, M., Mascolo, M., and Pane, F.
- Abstract
We evaluated the impact on progression-free survival (PFS) of achieving a deep metabolic response at 2-deoxy-2[18F] fluoro-d-glucose positron emission tomography (FDG-PET) in patients with refractory or relapsed (R/R) classic Hodgkin lymphoma (cHL) following a new salvage regimen named Bv+Bs (brentuximab vedotin + bendamustine supercharge), from 2013 to 2017. In this real-life study, 20 consecutive patients (aged <60 years) with R/R cHL after failure of ≥1 salvage treatments received Bv+Bs regimen consisting of 3-days outpatient IV infusions of 1.8 mg/kg of Bv on day 1 of each 3-week cycle combined in sequence to bendamustine on days 2 and 3 of the treatment cycle at a fixed dose of 120 mg/m2 per day, for a total of 4 courses. A robust primary prophylaxis approach, including premedication, antimicrobials, stimulating factors, and cytomegalovirus monitoring, was systematically performed. The 20 patients (all evaluable) underwent 4 courses of Bv+Bs with a median dose intensity of 100% for both Bv and Bs. Ten patients (50%) experienced grade ≥3 treatment-related adverse events, without requiring hospitalization. At post-Bv+Bs reevaluation, 80% of patients had deep metabolic responses with Deauville 5-point scale scores ≤2. Thereafter, 14 patients (70%) received autologous hematopoietic stem cell transplantation (HSCT; peripheral blood stem cells previously harvested in 12 cases), and 4 patients (10%) received allogeneic HSCT. At a median follow-up of 27 months from Bv+Bs regimen initiation, the 2-year PFS of the entire population was 93.7% (95% confidence interval, 62.7% to 99.6%). Our data suggest that Bv+Bs regimen-driven strategy may be a promising salvage option to improve long-term control of high-risk Hodgkin lymphoma.
- Published
- 2019
- Full Text
- View/download PDF
4. Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
- Author
-
Picardi, M., Della Pepa, R., Giordano, C., Pugliese, N., Mortaruolo, C., Trastulli, F., Rascato, M.G., Cappuccio, I., Raimondo, M., Memoli, M., Monteverde, M., Mascolo, M., and Pane, F.
- Abstract
We evaluated the impact on progression-free survival (PFS) of achieving a deep metabolic response at 2-deoxy-2[18F] fluoro-d-glucose positron emission tomography (FDG-PET) in patients with refractory or relapsed (R/R) classic Hodgkin lymphoma (cHL) following a new salvage regimen named Bv+Bs (brentuximab vedotin + bendamustine supercharge), from 2013 to 2017. In this real-life study, 20 consecutive patients (aged <60 years) with R/R cHL after failure of ≥1 salvage treatments received Bv+Bs regimen consisting of 3-days outpatient IV infusions of 1.8 mg/kg of Bv on day 1 of each 3-week cycle combined in sequence to bendamustine on days 2 and 3 of the treatment cycle at a fixed dose of 120 mg/m2per day, for a total of 4 courses. A robust primary prophylaxis approach, including premedication, antimicrobials, stimulating factors, and cytomegalovirus monitoring, was systematically performed. The 20 patients (all evaluable) underwent 4 courses of Bv+Bs with a median dose intensity of 100% for both Bv and Bs. Ten patients (50%) experienced grade ≥3 treatment-related adverse events, without requiring hospitalization. At post-Bv+Bs reevaluation, 80% of patients had deep metabolic responses with Deauville 5-point scale scores ≤2. Thereafter, 14 patients (70%) received autologous hematopoietic stem cell transplantation (HSCT; peripheral blood stem cells previously harvested in 12 cases), and 4 patients (10%) received allogeneic HSCT. At a median follow-up of 27 months from Bv+Bs regimen initiation, the 2-year PFS of the entire population was 93.7% (95% confidence interval, 62.7% to 99.6%). Our data suggest that Bv+Bs regimen-driven strategy may be a promising salvage option to improve long-term control of high-risk Hodgkin lymphoma.
- Published
- 2019
- Full Text
- View/download PDF
5. LABORATORY METHODS FOR THE DIAGNOSIS OF ASTHENOZOOSPERMIA
- Author
-
Curi, S., Ariagno, J., Repetto, H., Chenlo, P., Mendeluk, G., Pugliese, N., Sardi, M., and Blanco, A.
- Abstract
Human sperm samples from 46 men were evaluated for standard semen parameters by two trained technicians, according to WHO criteria. A computer-aided semen analyzer (CASA, HTM-IVOS) was employed. The overall mean coefficient of variation for the 2 participants and the 46 samples studied was 17% for the percentage of progressive motile spermatozoa ( r = 0.77). Twenty-nine (63%) samples were classified as asthenozoospermia by both methods. From the studied samples, 12 (26%) were classified as asthenozoospermia by the subjective method and 2 (4.3%) by CASA ( p = .01). The two methods do not provide directly comparable data.
- Published
- 2002
- Full Text
- View/download PDF
6. SHEDDING OF IMMATURE GERM CELLS
- Author
-
Ariagno, J., Curi, S., Mendeluk, G., Grinspon, D., Repetto, H., Chenlo, P., Pugliese, N., Sardi, M., and Blanco, A. M.
- Abstract
The immature germ cells (IGC) constitute the highest percentage (90%) of nonsperm cells (NSpC) in ejaculates from fertile or infertile men. The objective of this study was to evaluate IGC concentration and the IGC/(IGC + Sp) ratio, in normozoospermia and dispermia. Normozoospermia from men with proven fertility (NPF), nonproven fertility (NNPF), dispermia (D) and semen samples with excessive shedding of immature germ cells (G I : 1.7 ×10 6 to 5 ×10 6 IGC/mL and G II > 5.0 ×10 6 IGC/mL) were used in this study. The mean value + 2 SD for the NNPF (1.7 ×10 6 /mL) and the value proposed by WHO (5 ×10 6 /mL) were employed to define G I and G II groups. IGC concentration is statistically different in the studied groups. The IGC/Sp ratio showed a significant difference only between the NNPF and the D. When comparing semen parameters (Sp/ejaculate, grade (a) motility and morphology) there was a highly significant difference between NNPF and G I and G II ; no difference was found between G I and G II . While studying 200 cases of dispermias 83% showed a high shedding of immature germ cells. The cytological study of nonsperm cells and the count and identification of the immature germ cells could be used to evaluate the dispermic disorders.
- Published
- 2002
- Full Text
- View/download PDF
7. Poster session 5
- Author
-
Colunga Blanco, S, Garcia Campos, A, Capin Sampedro, E, Corros Vicente, C, Martin Fernandez, M, Leon Arguero, V, Fidalgo Arguelles, A, Velasco Alonso, E, Lopez Iglesias, F, De La Hera Galarza, JM, Gonzalez Matos, C, Chaparro-Munoz, M, Recio-Mayoral, A, Angelis, A, Vlachopoulos, C, Ioakeimidis, N, Felekos, I, Abdelrasoul, M, Aznaouridis, K, Chrysohoou, C, Rousakis, G, Aggeli, K, Tousoulis, D, Dinis, P G, Faustino, AC, Paiva, L, Fernandes, A, Costa, M, Cachulo, MC, Goncalves, L, Chinali, M, Emma, F, Rinelli, G, Esposito, C, Franceschini, A, Doyon, A, Raimondi, F, Schaefer, F, Pongiglione, G, Mateucci, MC, Toth, A, Vago, H, Juhasz, C, Janosa, C, Oprea, V, Balint, OH, Temesvari, A, Simor, T, Kadar, K, Merkely, B, Andreassi, M G, Bruno, R M, Borghini, A, Stea, F, Gargani, L, Mercuri, A, Sicari, R, Picano, E, Rodriguez Munoz, D, Lozano Granero, C, Carbonell San Roman, A, Moya Mur, JL, Fernandez-Golfin, C, Moreno Planas, J, Fernandez Santos, S, Casas Rojo, E, Hernandez-Madrid, A, Zamorano Gomez, JL, Reid, A B, Pearce, K, Gamlin, W, Miller, C, Schmitt, M, Park, JH, Seong, IW, Kim, KH, Kim, MJ, Jung, HO, Sohn, IS, Park, SM, Cho, GY, Choi, JO, Park, SW, study, NORMAL, Shetye, A, Nazir, SA, Khan, JN, Singh, A, Kanagala, P, Squire, I, Mccann, GP, Novo, G, Di Lisi, D, Meschisi, MC, Brunco, V, Badalamenti, G, Bronte, E, Russo, A, Novo, S, De Marchi, S F, Von Tscharner, M, Urheim, S, Aakhus, S, Seiler, C, Schmalholz, S, Cikes, M, Biering-Sorensen, T, Cheng, S, Oparil, S, Izzo, J, Pitt, B, Solomon, SD, Smarz, K, Zaborska, B, Jaxa-Chamiec, T, Tysarowski, M, Budaj, A, Illatopa, V, Cordova, F, Aguirre, O, Sanabria, S, Ortega, J, Peluso, D, Romeo, G, Perazzolo Marra, M, Tona, F, Famoso, G, Pigatto, E, Cozzi, F, Iliceto, S, Badano, LP, Wellnhofer, E, Kriatselis, C, Gerds-Li, JH, Kropf, M, Pieske, B, Graefe, M, De La Rosa Riestra, A, Martinez Santos, P, Batlle Lopez, E, Vilacosta, I, Sanchez Sauce, B, Espana Barrio, E, Jimenez Valtierra, J, Campuzano Ruiz, R, Alonso Bello, J, Martin Rios, MD, Sattarzadeh Badkoubeh, R, Farrashi, M, Abtahi, H, Sadeghi, H, Sadeghipour, P, Tavoosi, A, Mandour Ali, M, Abdel Rahman, TA, Mohamed, LA, Maghraby, HM, Kora, IM, Abdel Hameed, FR, Ali, MN, Azoz, A, Al Shehri, A, Youssef, A, Gad, A, Alsharqi, M, Alsaikhan, L, Pontone, G, Andreini, D, Rota, C, Guglielmo, M, Mushtaq, S, Baggiano, A, Beltrama, V, Solbiati, A, Guaricci, AI, Pepi, M, Krljanac, G, Trifunovic, D, Sobic Saranovic, D, Savic, L, Grozdic Milojevic, I, Asanin, M, Srdic, M, Petrovic, M, Zlaic, N, Mrdovic, I, Acar, R, Dogan, C, Izci, S, Gecmen, C, Unkun, T, Cap, M, Erdogan, E, Onal, C, Yilmaz, F, Ozdemir, N, Nucifora, G, Muser, D, Tioni, C, Zanuttini, D, Morocutti, G, Spedicato, L, Bernardi, G, Proclemer, A, Sirtautas, A, Pranevicius, R, Zapustas, N, Briedis, K, Valuckiene, Z, Jurkevicius, R, Roos, S T, Juffermans, LJM, Enait, V, Van Royen, N, Van Rossum, AC, Kamp, O, Qasem, M S, Khalaf, HASSEN, Hitham, SAKER, Osama, AS, Abazid, RAMI, Guall, RAHIM, Durdan, SHAFAT, Mohammed, ZYAD, Marini, C, Stella, S, Rosa, I, Ancona, F, Spartera, M, Italia, L, Latib, A, Colombo, A, Margonato, A, Agricola, E, Fabiani, I, Scatena, C, Mazzanti, C, Conte, L, Pugliese, N, Barletta, V, Bortolotti, U, Naccarato, AG, Di Bello, V, Gillis, K, Bala, G, Roosens, B, Hernot, S, Remory, I, Droogmans, S, Cosyns, B, Bandera, F, Generati, G, Labate, V, Donghi, V, Pellegrino, M, Carbone, F, Alfonzetti, E, Guazzi, M, Borowiec, A, Dabrowski, R, Kowalik, I, Firek, B, Chwyczko, T, Szwed, H, Lim, YJ, Kawamura, A, Kawano, S, Chalbia, T E, Zaroui, A, Ben Said, R, Ben Halima, M, Kheder, N, Farhati, A, Mourali, S, Mechmech, R, Santos, M, Leite, L, Martins, R, Baptista, R, Barbosa, A, Ribeiro, N, Oliveira, A, Castro, G, Pego, M, Gao, S A, Polte, C L, Lagerstrand, K, Johnsson, A A, Janulewicz, M, Bech-Hanssen, O, Zilberszac, R, Gabriel, H, Wisser, W, Maurer, G, Rosenhek, R, Farrag, AAM, El Aroussy, W, Abdel Ghany, M, Al Adeeb, K, Palmiero, G, Ascione, L, Carlomagno, G, Sordelli, C, Ferro, A, Ascione, R, Severino, S, Caso, P, Aruta, P, Muraru, D, Janei, C, Haertel Miglioranza, M, Cavalli, G, Romeo, G, Peluso, D, Cucchini, U, Iliceto, S, Badano, L, De Diego Soler, O, Armario Bel, X, Garcia-Garcia, C, Ferrer Sistach, E, Rueda Sobella, F, Oliveras Vila, T, Labata Salvador, C, Serra Flores, J, Lopez-Ayerbe, J, Bayes-Genis, A, Fasano, D, Conte, E, Gonella, A, Morena, L, Civelli, D, Losardo, L, Margaria, F, Riva, L, Tanga, M, Tamborini, G, Carminati, C, Muratori, M, Gripari, P, Ghulam Ali, S, Fusini, L, Vignati, C, Bartorelli, AL, Alamanni, F, Pepi, M, Ancona, F, Rosa, I, Stella, S, Marini, C, Spartera, M, Latib, A, Montorfano, M, Colombo, A, Margonato, A, Agricola, E, Raafat, D M, Ismaiel, A, Ali, N, Amry, S, Medicine, Faculty of, University, Assiut, Assiut, Egypt, Department, Pediatric, Marchel, M, Serafin, A, Kochanowski, J, Filipiak, KJ, Opolski, G, De Gregorio, C, Speranza, G, Ando', G, Magaudda, L, Gommans, D H F, Cramer, GE, Bakker, J, Michels, M, Dieker, HJ, Fouraux, MA, Marcelis, CLM, Timmermans, J, Brouwer, MA, Kofflard, MJM, Godinho, A R, Vasconcelos, M, Araujo, V, Almeida, P, Sousa, C, Macedo, F, Cardoso, JS, Maciel, MJ, Mielczarek, M, Voilliot, D, Huttin, O, Venner, C, Olivier, A, Villemin, T, Deballon, R, Manenti, V, Juilliere, Y, Selton-Suty, C, Bandera, F, Generati, G, Pellegrino, M, Labate, V, Carbone, F, Alfonzetti, E, Guazzi, M, Kubik, M, Dabrowska-Kugacka, A, Dorniak, K, Lewicka, E, Szalewska, D, Kutniewska-Kubik, M, Raczak, G, Cho, J Y, Kim, K H, Yoon, H J, Park, H J, Ahn, Y, Jeong, M H, Cho, J G, Park, J C, Kim, J H, Tarando, F, Galli, E, Habib, G, Schnell, F, Lederlin, M, Daubert, JC, Mabo, P, Donal, E, Lourenco Marmelo, B F, Faria, R, Magalhaes, P, Marques, N, Domingues, K, Lourenco, C, Almeida, AR, Teles, L, Picarra, B, Azevedo, O, SUNSHINE, Grupo, Reis, L, Lourenco, C, Oliveira, M, Magalhaes, P, Domingues, K, Marmelo, B, Almeida, A, Picarra, B, Faria, R, Marques, N, Sunshine, Domingues, K, Bento, D, Lourenco, C, Magalhaes, P, Cruz, I, Marmelo, B, Reis, L, Picarra, B, Faria, R, Azevedo, O, group, Sunshine, Krestjyaninov, MV, Gimaev, RH, Melnikova, MA, Olezov, NV, Ruzov, VI, Mesquita, J, Goncalves, P, Almeida, M S, Branco, P, Carvalho, M S, Dores, H, Gaspar, M A, Sousa, H, Andrade, M J, Mendes, M, Ikonomidis, I, Makavos, G, Varoudi, M, Papadavid, E, Andreadou, I, Gravanis, K, Liarakos, N, Pavlidis, G, Rigopoulos, D, Lekakis, J, Ferferieva, V, Deluyker, D, Bito, V, Peluso, D, Pigatto, E, Romeo, G, Muraru, D, Cozzi, F, Punzi, L, Iliceto, S, Badano, LP, Peluso, D, Pigatto, E, Romeo, G, Muraru, D, Cozzi, F, Iliceto, S, Badano, LP, King, GJ, Neilan, T, Coen, K, Gannon, S, Bennet, K, Clarke, JG, D'ascenzi, F, Solari, M, Cameli, M, Focardi, M, Corrado, D, Bonifazi, M, Henein, M, Mondillo, S, Ferrera Duran, C, Gomez-Escalonilla, C, De Agustin, A, Egido, J, Islas, F, Simal, P, Gomez De Diego, JJ, Luaces, M, Macaya, C, Perez De Isla, L, Sormani, P, Zancanella, M, Rusconi, C, Musca, F, Santambrogio, G, De Chiara, B, Vallerio, P, Cairoli, R, Giannattasio, G, Moreo, A, Gonzalez Fernandez, O, Alvarez Ortega, C, Mori Junco, R, Caro Codon, J, Meras Colunga, P, Ponz De Antonio, I, Lopez Fernandez, T, Valbuena Lopez, S, Moreno Yanguela, M, Lopez-Sendon, JL, Tereshina, O, Surkova, E, Cambronero Cortinas, E, Bonanad-Lozano, C, Lopez-Lereu, MP, Monmeneu-Menadas, JV, Gavara, J, De Dios, E, Paya-Chaume, A, Escribano-Alarcon, D, Chorro-Gasco, FJ, Bodi-Peris, V, Kupczynska, K, Michalski, BW, Miskowiec, D, Kasprzak, JD, Lipiec, P, Carvalho, J F, Morgado, G, Caldeira, D, Cruz, I, Joao, I, Almeida, A R, Lopes, L, Fazendas, P, Cotrim, C, Pereira, H, Shivalkar, B, De Block, C, Buys, D, Salgado, R, Vrints, C, Van Gaal, L, Aghamohammadzadeh, R, Mctear, C, Irwin, RB, Cifra, B, Dragulescu, A, Friedberg, M, Mertens, L, Cifra, B, Dragulescu, A, Friedberg, M, Mertens, L, Bandera, F, Carbone, F, Generati, G, Pellegrino, M, Labate, V, Alfonzetti, E, Guazzi, M, Kuznetsov, VA, Krinochkin, DV, Yaroslavskaya, EI, Zaharova, EH, Pushkarev, GS, Van Zalen, JJ, Sugihara, C, Patel, NR, Sulke, AN, Lloyd, GW, Kochanowski, J, Piatkowski, R, Scislo, P, Grabowski, M, Marchel, M, Opolski, G, Goebel, B, Roland, H, Hamadanchi, A, Otto, S, Jung, C, Lauten, A, Figulla, HC, Poerner, TC, Ladeiras-Lopes, R, Sampaio, F, Fonseca, P, Fontes-Carvalho, R, Pinho, M, Campos, AS, Castro, P, Fonseca, C, Ribeiro, J, Gama, V, Goebel, B, Heck, R, Hamdanchi, A, Otto, S, Jung, C, Lauten, A, Figulla, HR, Poerner, TC, Karvandi, M, Ranjbar, S, Ghaffaripour Jahromi, M, Karvandi, M, Ranjbar, S, Alonso Salinas, G, Hinojar, R, Fernandez Golfin, C, Esteban, A, Pascual-Izco, M, Garcia-Martin, A, Casas Rojo, E, Jimenez-Nacher, JJ, Zamorano, JL, Unkun, T, Gecmen, C, Cap, M, Izci, S, Erdogan, E, Onal, C, Acar, R, Bakal, RB, Kaymaz, C, Ozdemir, N, Ranjbar, S, Karvandi, M, Ghaffaripour Jahromi, M, Hubert, A, Galand, V, Schnell, F, Matelot, D, Martins, R, Leclercq, C, Carre, F, Enescu, OA, Suran, BC, Margulescu, AD, Rimbas, RC, Siliste, C, Vinereanu, D, Liccardo, M, Nocerino, P, Urso, AC, Borrino, A, Carbone, C, Follero, P, Ciardiello, C, Prato, L, Salzano, G, Cameli, M, Marino, F, Ruspetti, A, Sparla, S, Di Tommaso, C, Loiacono, F, Focardi, M, D'ascenzi, F, Henein, M, Mondillo, S, Ako, E, Porter, J, Walker, M, Lembo, M, Lo Iudice, F, Esposito, R, Santoro, C, Cocozza, S, Izzo, R, De Luca, N, De Simone, G, Trimarco, B, Galderisi, M, Goffredo, C, Gervasi, F, Patti, G, Mega, S, Bono, M, Di Sciascio, G, Enache, R, Buture, A, Badea, R, Platon, P, Ghiorghiu, I, Jurcut, R, Coman, IM, Popescu, BA, Ginghina, C, Novo, G, Lunetta, M, Spoto, MS, Lo Vi, AM, Pensabene, G, Meschisi, MC, Carita, P, Coppola, G, Novo, S, Assennato, P, Wdowiak-Okrojek, K, Shim, A, Wejner-Mik, P, Kasprzak, JD, Lipiec, P, Nemes, A, Havasi, K, Domsik, P, Kalapos, A, Forster, T, Nemes, A, Piros, GA, Domsik, P, Kalapos, A, Lengyel, C, Orosz, A, Forster, T, Di Salvo, G, Bulbul, Z, Issa, Z, Al Sehly, A, Pergola, V, Oufi, S, Capotosto, L, Conde, Y, Cimino, E, Rinaldi, E, Ashurov, R, Ricci, S, Pergolini, M, Vitarelli, A, Caravaca, P, Lujan Valencia, JE, Chaparro, M, Garcia-Guerrero, A, Cristo Ropero, MJ, Izquierdo Bajo, A, Madrona, L, Recio-Mayoral, A, Maceira Gonzalez, A M, Monmeneu, JV, Igual, B, Lopez Lereu, P, Garcia, MP, Iriart, X, Selmi, W, Jalal, Z, Thambo, JB, Jug, B, Kosuta, D, and Fras, Z
- Abstract
Background: Handheld ultrasound devices allow for a bedside screening although quantitative parameters are not easily obtained. We aim to assess the reliability of visual qualitative evaluation of left ventricle (LV) compared with standard quantitative evaluation with 2D transthoracic echocardiography (TTE). Methods: Two cardiologists have reviewed 135 consecutive standard TTE examinations. Both observers visually assessed LV size, hypertrophy (LVH) and ejection fraction (EF). LV diameter, volume, wall thickness and EF (Teichholz and Simpson) were also measured by both observers. Visual and quantitative agreement and inter and intraobserver variability were calculated. Results: Image quality allowed for evaluation of 130 examinations. Visually assessed EF compared with Simpson had better consistency (Intraclass correlation coefficient [ICC] 0,91 IC95% 0,88-0,94) than with Teichholz (ICC 0,75 IC95% 0,66-0,82). We have also observed good interobserver agreement regarding visually assessed EF (ICC 0,81 IC95% 0,71-0,87) and Simpson EF (ICC 0,80 IC95% 0,70-0,89) as well as good intraobserver agreement (visual EF: ICC 0,81 IC95% 0,74-0,86; Simpson: ICC 0,89 IC95% 0,84-0,93). Regarding LVH we found moderate agreement between visual and quantitative assessment (weighted Kappa [wK] 0,44 (IC95% 0,32-0,56)), moderate interobserver agreement for quantitative assessment (ICC 0,59 IC95% 0,44-0,71) and poor interobserver agreement for visual assessment (wK 0,19 IC95% 0,08-0,30). Intraobserver variability regarding LVH visual estimation was moderate (wK 0,40 IC95% 0,29-0,52) and regarding LVH quantification was good (ICC 0,78 IC95% 0,70-0,84). LVH was visually overestimated in 25% of examinations. Regarding LV size, we found poor agreement between visual assessment and its quantification with end-diastolic diameter (wK 0,22 IC95% 0,06-0,39) and moderate agreement between visual assessment and end-systolic LV volume (wK 0,62 IC95% 0,47-0,77). Interobserver agreement regarding quantitative volume assessment was good (ICC 0,90 IC95% 0,85-0,94) and regarding visual assessment was moderate (wK 0,43 IC95% 0,26-0,70). We found good intraobserver variability of volume measurement (wK 0,64 IC95% 0,50-0,78) and of visual size assessment (ICC 0,96 IC95% 0,94-0,97). Conclusions: Visual LVEF assessment is consistent with quantitative assessment and should be regarded as a reliable parameter that can be obtained from bedside examination with a handheld device. Visual assessment of LV size and wall thickness is less reliable than its quantification and should be confirmed with standard measurements.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.